Adc Therapeutics Sa Adc Therapeutics Doses First Patient In Pivotal Clinical | Latest News RSS feed

Adc Therapeutics Sa Adc Therapeutics Doses First Patient In Pivotal Clinical - Latest News


ADC Therapeutics Doses First Patient in Phase Ib Clinical Trial of ADCT-301 in Patients with Advanced Solid Tumors

At the 2018 American Society of Hematology (ASH) Annual Meeting, ADC Therapeutics presented interim data on 113 patients dosed in its ... complete response rate, at the dose being considered for a ... read more

ADC Therapeutics SA - ADC Therapeutics Doses First Patient in Pivotal Clinical ...

Phase II trial evaluating efficacy and safety of CD19-targeting antibody drug conjugate intended to support submission of Biologics License Application Top-line data expected in third quarter of 2019 ... read more

ADC Therapeutics Doses First Patient in Phase I Trial of ADCT-301 Trial in Acute Myeloid Leukemia

LAUSANNE, Switzerland & LONDON & MURRAY HILL,N.J.--(BUSINESS WIRE)--ADC Therapeutics SA (ADCT), the oncology drug development company, announces that the first ... The initial dose escalation phase ... read more

Looking for another news?


ADC Therapeutics SA: ADC Therapeutics Doses First Patient in Phase Ib Clinical Trial of ADCT-301 in Patients with Advanced Solid Tumors

At the 2018 American Society of Hematology (ASH) Annual Meeting, ADC Therapeutics presented interim data on 113 patients dosed in its ... complete response rate, at the dose being considered for a ... read more


EQS-News: ADC Therapeutics Doses First Patient in Phase Ib Clinical Trial of ADCT-301 in Patients with Advanced Solid Tumors

Lausanne, Switzerland, January 4, 2019 - ADC Therapeutics, an oncology drug discovery and development company that specializes in the development of proprietary antibody drug conjugates (ADCs), today ... read more

ADC Therapeutics Announces First Patient Dosed in Phase I Clinical Trial of ADCT-601 in Advanced Solid Tumors

The identified dose will be evaluated in the dose-expansion part. Approximately 75 patients ... clinical trials, ranging from first in human to pivotal Phase II, in the USA and Europe, and a deep ... read more

EQS-News: ADC Therapeutics Doses First Patient in Phase Ib Clinical Trial of ADCT-301 in Patients with Advanced Solid Tumors

EQS Group-News: ADC Therapeutics SA / Key word(s): Study ADC Therapeutics Doses First Patient in Phase Ib Clinical Trial ... at the dose being considered for a pivotal Phase II clinical trial that the ... read more

ADC Therapeutics SA - ADC Therapeutics Presents Updated Data from Clinical Trials of Novel Antibody Drug Conjugates

“We are encouraged by the safety profiles and strong single-agent anti-tumor activity we continue to observe in the 183-patient first ... a Phase Ib clinical trial in solid tumors (NCT03621982). About ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us